Intracellular Distribution of Microinjected Antisense Oligonucleotides

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1991 Apr 1

PMID 1849273

Citations 80

Authors

J P Leonetti

N Mechti

G Degols

C Gagnor

B Lebleu

Affiliations

Soon will be listed here.

Abstract

Antisense oligomers constitute an attractive class of specific tools for genetic analysis and for potential therapeutic applications. Targets with different cellular locations have been described, such as mRNA translation initiation sites, pre-mRNA splicing sites, or the genes themselves. However the mechanism(s) of action and the intracellular distribution of antisense oligomers remain poorly understood. Antisense oligomers conjugated with various fluorochromes or with BrdUrd were microinjected into the cytoplasm of somatic cells, and their cellular distribution was monitored by fluorescence microscopy in fixed and nonfixed cells. A fast translocation in the nuclei and a concentration on nuclear structures were observed whatever probe was used. Nuclear transport occurs by diffusion since it is not affected by depletion of the intracellular ATP pool, temperature, or excess unlabeled oligomer. Accumulation of the oligomers in the nuclei essentially takes place on a set of proteins preferentially extracted between 0.2 M and 0.4 M NaCl as revealed by crosslinking of photosensitive oligomers. The relationship between nuclear location of antisense oligomers and their mechanism of action remains to be ascertained and could be of major interest in the design of more efficient antisense molecules.

Citing Articles

Development of a macrophage polarization-modulating therapeutic agent for osteoarthritis treatment.

Wu L, Cao X, Shen B J Orthop Surg Res. 2025; 20(1):279.

PMID: 40082923 PMC: 11908040. DOI: 10.1186/s13018-025-05679-2.

Endosomal Escape and Nuclear Localization: Critical Barriers for Therapeutic Nucleic Acids.

Allen R, Yokota T Molecules. 2025; 29(24.

PMID: 39770086 PMC: 11677605. DOI: 10.3390/molecules29245997.

Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1.

De Serres-Berard T, Ait Benichou S, Jauvin D, Boutjdir M, Puymirat J, Chahine M Int J Mol Sci. 2022; 23(21).

PMID: 36362145 PMC: 9657934. DOI: 10.3390/ijms232113359.

gEL DNA: A Cloning- and Polymerase Chain Reaction-Free Method for CRISPR-Based Multiplexed Genome Editing.

Randazzo P, Bennis N, Daran J, Daran-Lapujade P CRISPR J. 2021; 4(6):896-913.

PMID: 33900846 PMC: 8742297. DOI: 10.1089/crispr.2020.0028.

Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs.

Fumoto S, Yamamoto T, Okami K, Maemura Y, Terada C, Yamayoshi A Pharmaceutics. 2021; 13(2).

PMID: 33530309 PMC: 7911509. DOI: 10.3390/pharmaceutics13020159.

References

Goldfarb D, Gariepy J, Schoolnik G, Kornberg R . Synthetic peptides as nuclear localization signals. Nature. 1986; 322(6080):641-4. DOI: 10.1038/322641a0. View

Goodchild J . Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties. Bioconjug Chem. 1990; 1(3):165-87. DOI: 10.1021/bc00003a001. View

Eckstein F . Nucleoside phosphorothioates. Annu Rev Biochem. 1985; 54:367-402. DOI: 10.1146/annurev.bi.54.070185.002055. View

Yakubov L, Deeva E, Zarytova V, Ivanova E, Ryte A, Yurchenko L . Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?. Proc Natl Acad Sci U S A. 1989; 86(17):6454-8. PMC: 297862. DOI: 10.1073/pnas.86.17.6454. View

Lemaitre M, Bayard B, Lebleu B . Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc Natl Acad Sci U S A. 1987; 84(3):648-52. PMC: 304272. DOI: 10.1073/pnas.84.3.648. View

Picard D, Salser S, Yamamoto K . A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell. 1988; 54(7):1073-80. DOI: 10.1016/0092-8674(88)90122-5. View

Thenet S, Morvan F, Bertrand J, Gautie C, Malvy C . Alpha are more stable than beta anomer oligonucleotides in 3T3 cellular extracts. Biochimie. 1988; 70(12):1729-32. DOI: 10.1016/0300-9084(88)90031-4. View

Baeuerle P, Baltimore D . I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science. 1988; 242(4878):540-6. DOI: 10.1126/science.3140380. View

Kulka M, Smith C, Aurelian L, Fishelevich R, Meade K, Miller P . Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4. Proc Natl Acad Sci U S A. 1989; 86(18):6868-72. PMC: 297951. DOI: 10.1073/pnas.86.18.6868. View

10.

Boutorin A, Guskova L, Ivanova E, Kobetz N, Zarytova V, Ryte A . Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3'-terminus and their interaction with DNA within mammalian cells. FEBS Lett. 1989; 254(1-2):129-32. DOI: 10.1016/0014-5793(89)81023-3. View

11.

Loke S, Stein C, Zhang X, Mori K, Nakanishi M, Subasinghe C . Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci U S A. 1989; 86(10):3474-8. PMC: 287160. DOI: 10.1073/pnas.86.10.3474. View

12.

Heikkila R, Schwab G, Wickstrom E, Loke S, PLUZNIK D, Watt R . A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature. 1987; 328(6129):445-9. DOI: 10.1038/328445a0. View

13.

WACHTER L, Jablonski J, Ramachandran K . A simple and efficient procedure for the synthesis of 5'-aminoalkyl oligodeoxynucleotides. Nucleic Acids Res. 1986; 14(20):7985-94. PMC: 311829. DOI: 10.1093/nar/14.20.7985. View

14.

McManaway M, Neckers L, Loke S, Al-Nasser A, Redner R, Shiramizu B . Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. Lancet. 1990; 335(8693):808-11. DOI: 10.1016/0140-6736(90)90934-w. View

15.

Helene C, Toulme J . Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta. 1990; 1049(2):99-125. DOI: 10.1016/0167-4781(90)90031-v. View

16.

Breeuwer M, Goldfarb D . Facilitated nuclear transport of histone H1 and other small nucleophilic proteins. Cell. 1990; 60(6):999-1008. DOI: 10.1016/0092-8674(90)90348-i. View

17.

BARSONY J, Marx S . Immunocytology on microwave-fixed cells reveals rapid and agonist-specific changes in subcellular accumulation patterns for cAMP or cGMP. Proc Natl Acad Sci U S A. 1990; 87(3):1188-92. PMC: 53436. DOI: 10.1073/pnas.87.3.1188. View

18.

Dignam J, Lebovitz R, Roeder R . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11(5):1475-89. PMC: 325809. DOI: 10.1093/nar/11.5.1475. View

19.

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

20.

Lang I, Scholz M, Peters R . Molecular mobility and nucleocytoplasmic flux in hepatoma cells. J Cell Biol. 1986; 102(4):1183-90. PMC: 2114189. DOI: 10.1083/jcb.102.4.1183. View